Clinical trial

Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)

NCT00784849

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-11-01

PhasePHASE2

Study timeline

Study start (unknown)2004-11-01Date precision: month

Registry last updated2012-06-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

Methylene blueDRUG · verified · RxNorm: methylene blue

Sponsors & collaborators

Louisiana State University Health Sciences Center in New Orleanslead sponsor

Mapped research locations

New OrleansLouisiana, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00784849 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.